ANCA-associated vasculitis (AAV). Wegener disease, microscopic polyangitis, and Churg-Strauss syndrome;ANCA-assoziierte vaskulitiden (AAV): Morbus Wegener, mikroskopische polyangiitis und Churg-Strauss-Syndrom

HNO

Volumn 45, Issue 6, 1997, Pages 477-491

  Schmitt, W H ^a,c   Paulsen, J ^b   Rudert, H ^b   Gross, W L ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

^b UNIVERSITY OF KIEL   (Germany)

^c Rheumaklinik Bad Bramstedt   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

NEUTROPHIL CYTOPLASMIC ANTIBODY;

ARTICLE; CHURG STRAUSS SYNDROME; CLINICAL FEATURE; CONTINUING EDUCATION; HUMAN; IMMUNOPATHOGENESIS; VASCULITIS; WEGENER GRANULOMATOSIS;

ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; ARTERIES; CHURG-STRAUSS SYNDROME; DIAGNOSIS, DIFFERENTIAL; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; OTORHINOLARYNGOLOGIC DISEASES; PREDICTIVE VALUE OF TESTS; VASCULITIS; WEGENER GRANULOMATOSIS;

EID: 0030745190     PISSN: 00176192     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Cohen Tervaert JW, Huitema MG, Hene RJ, Sluiter WJ, The TH, van der Hem GH, Kallenberg CGM (1990) Prevention of relapses in Wegener's granulomatosis by treatment based on antineutrophil cytoplasmic antibody titre. LANCET 336: 709
2. Falk RJ, Jennette JC (1988) Antineutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic and crescentic glomerulonephritis. N Engl.J Med 318: 1651
3. Gross WL, Csernok E (1995) lmmunodiagnostic and pathophysiologic aspects of antineutrophil cytoplasmic antibodies in vasculitis. Curr Op Rheumatol 7: 11-19
4. Hagen EC (1993) Standardization of ELISA's for the detection of antiproteinase-3 (PR-3) and antimyeloperoxidase (MPO) antibodies. Clin Ext Immunol 93 [Suppl 1]: 32
5. Huffman GS, Kerr GS, Leavitt RY, Hallahan CW (1992) Wegener's granulomatosis: an analysis of 158 patients Ann Inter Med 116: 488
6. Kallenberg CGM, Brouwer E, Weening JJ, Cohen Tervaert JW (1994) Antineutrophil cytoplasmic antibodies: Current diagnostic and pathophysiological potential. Kidney Int 46: 1-15
7. Langford, CA, Sneller MC, Hallahan CW, Huffman GS, Kammerer WA, Talar-Williams C, Fauci AS, Lebovics RS (1996) Clinical Features and Therapeutic Management of Subglottic Stenosis in Patients with Wegener's Granulomatosis. Arthritis Rheum 39: 1754-1760
8. Ludemann J, Utecht B, Gross WL (1990) Anti-neutrophil cytoplasm antibodies in Wegener's granulomatosis recognize an elastinolytic enzyme. J Exp Med 171: 357-362
9. Nölle B, Specks U, Lüdemann J, Rohrbach MS, DeRemee RA, Gross WL (1989) Anticytoplasmic autoantibodies: Their imunnodiagnostic value in Wegener's granulomatosis. Ann Int Med 111: 28-40
10. Schmitt WH, Heesen C, Csernok E, Rautmann A, Gross W.L. (1992) Elevated serum levels of soluble interelukin-2 receptor in patients with Wegener's granulomatosis. Arthritis Rheum 35: 1088-1096
11. van der Woude FJ Rasmussen N Lobatto S Wiik A Permin H van Es LA van der Giessen M van der Hem GK The TH (1985) Autoantibodies against neutrophils and monocytes: Tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet 1: 425-429